<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>ELIFE on Michael’s Domain</title><link>https://jeltsch.org/en/tags/elife/</link><description>Recent content in ELIFE on Michael’s Domain</description><generator>Hugo</generator><language>en-us</language><copyright>Copyright © 2002 - 2026 Michael Jeltsch.</copyright><lastBuildDate>Fri, 24 Jul 2026 00:18:18 +0300</lastBuildDate><atom:link href="https://jeltsch.org/en/tags/elife/index.xml" rel="self" type="application/rss+xml"/><item><title>Finnish abstract of our recent work about PSA (Prostate-specific antigen) in Duodecim</title><link>https://jeltsch.org/en/finnish_abstract_of_our_recent_work_about_psa_prostate_specific_antigen_in_duodecim/</link><pubDate>Sun, 25 Aug 2019 00:00:00 +0000</pubDate><guid>https://jeltsch.org/en/finnish_abstract_of_our_recent_work_about_psa_prostate_specific_antigen_in_duodecim/</guid><description>&lt;p&gt;There is a nice Finnish language abstract about our recent finding that PSA (Prostate-specific antigen) activates VEGF-C and VEGF-D in the Finnish medical journal &lt;strong&gt;Duodecim&lt;/strong&gt;: Eturauhassyövän merkkiaine PSA aktivoi syövän leviämiseen osallistuvia veri- ja imusuonikasvutekijöitä (
 &lt;a href="https://www.duodecimlehti.fi/lehti/2019/15/duo15024" target="_blank" rel="noopener noreferrer nofollow"&gt;https://www.duodecimlehti.fi/lehti/2019/15/duo15024&amp;nbsp;






 
 
 
 &lt;svg class="svg-inline--fa fas fa-up-right-from-square fa-2xs" fill="currentColor" aria-hidden="true" role="img" viewBox="0 0 512 512" overflow="visible"&gt;&lt;use href="#fas-up-right-from-square"&gt;&lt;/use&gt;&lt;/svg&gt;&lt;/a&gt;
 ). Given the dominant position of the English language in medical science (and life science in general). &lt;strong&gt;Duodecim&lt;/strong&gt; is arguably the only relevant, remaining Finnish language medical journal. &lt;strong&gt;Duodecim&lt;/strong&gt; is the publication of the homonymous Association of Finnish Medical Doctors.&lt;/p&gt;</description></item><item><title>Re-purposing the growth factor VEGF-C</title><link>https://jeltsch.org/en/re_purposing_the_growth_factor_vegf_c/</link><pubDate>Sat, 22 Jun 2019 00:00:00 +0000</pubDate><guid>https://jeltsch.org/en/re_purposing_the_growth_factor_vegf_c/</guid><description>&lt;p&gt;An eLIFE digest features our recent publication about VEGF-C (
 &lt;a href="https://elifesciences.org/digests/44478/re-purposing-the-growth-factor-vegf-c" target="_blank" rel="noopener noreferrer nofollow"&gt;https://elifesciences.org/digests/44478/re-purposing-the-growth-factor-vegf-c&amp;nbsp;






 
 
 
 &lt;svg class="svg-inline--fa fas fa-up-right-from-square fa-2xs" fill="currentColor" aria-hidden="true" role="img" viewBox="0 0 512 512" overflow="visible"&gt;&lt;use href="#fas-up-right-from-square"&gt;&lt;/use&gt;&lt;/svg&gt;&lt;/a&gt;
 ). Even though our research did not deeply delve into the function of VEGF-C during reproduction, the reviewers comments and our answers (under the &amp;ldquo;Author response&amp;rdquo; heading) give more insight than the publication itself. We did not include the sperm motility data in the manuscript. Although sometimes stunning in its magnitude, we did not always measure increased sperm motility in response to active VEGF-C. As is common knowledge, sperm as a biological sample is of highly fluctuating consistency and quality. Interestingly, a paper in eLIFE published two years ago gives some additional insight in what we might be dealing with: 
 &lt;a href="https://elifesciences.org/articles/28811" target="_blank" rel="noopener noreferrer nofollow"&gt;Sperm competition risk drives rapid ejaculate adjustments mediated by seminal fluid&amp;nbsp;






 
 
 
 &lt;svg class="svg-inline--fa fas fa-up-right-from-square fa-2xs" fill="currentColor" aria-hidden="true" role="img" viewBox="0 0 512 512" overflow="visible"&gt;&lt;use href="#fas-up-right-from-square"&gt;&lt;/use&gt;&lt;/svg&gt;&lt;/a&gt;
. This paper shows that the swimming speed of sperm is rapidly regulated by males depending on the social situation (presence of a female or a male competitor). Imho, such factors seem to be almost impossible to control when dealing with human samples…However, the title ambiguously also refers to cancer. Based on our data, we speculate that VEGF-C can be repurposed from being lymphangiogenic to being angiogenic, and further, to be metastasis-promoting.&lt;/p&gt;</description></item></channel></rss>